Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock

Critical Care Medicine

Volumn 30, Issue 6, 2002, Pages 1365-1378

  Carcillo, Joseph A ^a   Fields, Alan I ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALDOSTERONE; AMRINONE; ANGIOTENSIN; ARGIPRESSIN; DOPAMINE; DOPEXAMINE; GLYCERYL TRINITRATE; HYDROCORTISONE; INOTROPIC AGENT; LIOTHYRONINE; MILRINONE; NITROPRUSSIDE SODIUM; NORADRENALIN; PENTOXIFYLLINE; PHENTOLAMINE; PHENYLEPHRINE; PHOSPHODIESTERASE INHIBITOR; PROSTACYCLIN;

ARTERIAL OXYGEN SATURATION; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; ECHOCARDIOGRAPHY; EVIDENCE BASED MEDICINE; EXTRACORPOREAL OXYGENATION; FLUID THERAPY; HEART FAILURE; HEART OUTPUT; HEMODYNAMICS; HUMAN; HYPEROXIA; MEDLINE; META ANALYSIS; MORTALITY; OXYGEN THERAPY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SEPTIC SHOCK; SHOCK; TREATMENT OUTCOME; UNITED STATES; VASCULAR RESISTANCE;

EID: 0036274931     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200206000-00040     Document Type: Article

References (162)

1. Infections due to Gram-negative organisms: An analysis of 860 patients with bacteremia at University of Minnesota Medical Center, 1958-1966
2. Decline in sepsis-associated neonatal and infant deaths: 1979 through 1994
3. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
4. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis
5. The effect of the immunomodulatory agent, pentoxyfilline in the treatment of sepsis in prematurely delivered infants: Placebo-controlled, double-blinded trial
6. Sumarmo: The role of steroids in dengue shock syndrome
7. Hydrocortisone in the management of dengue shock syndrome
8. Acute management of dengue shock syndrome: A randomized double-blind comparison of 4 intravenous fluid regimens in the first hour
9. Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: Heart rate as an early predictor of prognosis
10. Profound but reversible myocardial depression in patients with septic shock
11. Sequential cardiopulmonary variables of infants and children in septic shock
12. Distributions of cardiopulmonary variables in pediatric survivors and nonsurvivors of septic shock
13. Sequential physiologic interactions in cardiogenic and septic shock
14. Myocardial depression in septic shock caused by meningococcal infection
15. Hemodynamic patterns of meningococcal shock in children
16. Changes in left ventricular function in shocked newborns
17. Cardiac output in newborn infants with transient myocardial dysfunction
18. Severe left ventricular dysfunction and arrhythmias as complication of gram positive sepsis: Rapid recovery in children
19. Quantitated left ventricular systolic mechanics in children with septic shock utilizing noninvasive wall stress analysis
20. Hemodynamic support in fluid refractory pediatric septic shock
21. Awake porcine model of intraperitoneal sepsis and altered oxygen utilization
22. New perspectives in circulatory shock: Pathophysiologic mediators of the mammalian response to endotoxemia and sepsis
23. In vitro myocardial performance after lethal and nonlethal doses of endotoxin
24. Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock
25. The study of fecal E coli peritonitis-induced septic shock in a neonatal pig model
26. E coli endotoxin depresses left ventricular contractility in neonatal lambs
27. Myocardial dysfunction in group B streptococcal shock
28. Unsuspected mesenteric hypoperfusion despite apparent hemodynamic recovery in the early phase of septic shock in piglets
29. Early and late hemodynamic consequences of group B beta streptococcal sepsis in piglets: Effects on systemic, pulmonary, and mesenteric circulations
30. Echocardiographic assessment of cardiac function in shocked very low birthweight infants
31. Transient hypothyroidism associated with prematurity, sepsis, and respiratory distress
32. Early neonatal hypocalcemia
33. A short course of hydrocortisone in hypotensive neonates <1250 grams in the first 24 hours of life: A randomized, double-blind controlled trial
34. Appraising the potential of pentoxyfilline in septic premies
35. Early reversal of shock is associated with improved outcome during interfacility transport of pediatric septic shock
36. The effects of norepinephrine on hemodynamics and renal function in severe septic shock
37. Effects of perfusion pressure on tissue perfusion in septic shock
38. The importance of intra-abdominal pressure measurements in burned children
39. Early goal-directed therapy in the treatment of severe sepsis and septic shock
40. Pediatric emergency intravenous access: Evaluation of a protocol
41. High flow sheaths for pediatric fluid resuscitation: A comparison of flow rates with standard pediatric catheters
42. Role of early fluid resuscitation in pediatric septic shock
43. Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgous monkey
44. Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins
45. Cardiac output and organ blood flow in experimental septic shock and treatment with antibiotics, corticosteroids, and fluid infusion
46. Awake porcine model of intraperitoneal sepsis and altered oxygen utilization
47. Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis
48. Influence of different volume therapies and pentoxifylline infusion on circulating adhesion molecules in critically ill patients
49. Effect of large volume replacement with balanced electrolyte solutions on extravascular lung water in surgical patients with sepsis syndrome
50. Normalization of plasma arginine vasopressin concentrations when children with meningitis are given maintenance plus replacement fluid therapy
51. Effects of volume expansion on cardiac output in the preterm infant
52. Central-peripheral temperature difference, blood pressure, and arginine vasopressin in preterm neonates undergoing volume expansion
53. Group B streptococcal sepsis on the piglet: Effects of fluid therapy on venous return, organ edema, and organ blood flow
54. Emergency management of meningococcal disease
55. Human albumin administration in critically ill patients: Systematic review of randomized controlled trials
56. Does the type of volume therapy influence endothelial-related coagulation in the critically ill?
57. Dependence of oxygen consumption on oxygen delivery in children with hyperdynamic septic shock and low oxygen extraction
58. Effect of blood transfusion on oxygen consumption in pediatric septic shock
59. Pulmonary artery catheter consensus conference: Consensus statement
60. Comparison of gastric intramucosal pH and standard perfusional measurements in pediatric septic shock
61. Left ventricular failure complicating severe pediatric burn injury
62. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock: A prospective, double-blinded, randomized, placebo-controlled, interventional study
63. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock
64. Amrinone in pediatric refractory shock: An open label pharmacodynamic study
65. Continuous wave Doppler cardiac output: Use in pediatric patients receiving inotropic support
66. Usefulness of gastric intramucosal pH for monitoring hemodynamic complications in critically ill children
67. Predictors of mortality and multiple organ failure in children with sepsis
68. Gastric tonometry in septic shock
69. Prognostic value of gastric intramucosal pH in critically ill children
70. Continuous esophageal aortic blood flow echo-Doppler measurement during general anesthesia in infants
71. Clinical validation of cardiac output measurement using femoral artery thermodilution with direct Fick in ventilated children and adults
72. Comparison of pulmonary artery and thermodilution cardiac indices in pediatric intensive care patients
73. Pharmacokinetics of dopamine in critically ill newborn infants
74. Dopamine pharmacokinetics in critically ill newborn infants
75. Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children
76. Renal and hemodynamic effects of dopamine in infants following cardiac surgery
77. Benefits of high-dose dopamine in experimental neonatal septic shock
78. Cardiovascular response to dopamine in hypotensive preterm neonates with severe hyaline membrane disease
79. Dopamine pharmacokinetics in critically ill newborn infants
80. Impact on blood pressure and intestinal perfusion of dobutamine or dopamine in hypotensive preterm infants
81. Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome
82. Reversal of intractable septic shock with norepinephrine therapy
83. A reappraisal of norepinephrine therapy in human septic shock
84. Experience with phenylephrine as a component of the pharmacologic support of septic shock
85. Angiotensin for septic shock unresponsive to noradrenaline
86. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery
87. Plasma nitrite and nitrate concentrations and multiple organ failure in pediatric sepsis
88. Circulating methemoglobin and nitrite/nitrate concentrations as indicators of nitric oxide overproduction in critically ill children with septic shock
89. Measurements of total plasma nitrite and nitrate in pediatric patients with systemic inflammatory response syndrome
90. Activation of the L-arginine nitric oxide pathway in severe sepsis
91. Urinary nitrite excretion in low birthweight neonates with systemic inflammatory response syndrome
92. Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure
93. Nitric oxide production in critically ill patients
94. Nitric oxide in patient after burn injury
95. Increased serum nitrite and nitrate concentrations in children with sepsis syndrome
96. Multi-center, randomized, double blind, placebo-controlled, double bind study of nitric oxide inhibitor 546C88: Effect on survival in patients with septic shock
97. Effect of methylene blue on refractory neonatal hypotension
98. The need for inotropic support in a subgroup of infants with severe life threatening respiratory syncytial viral infection
99. Venous admixture in human septic shock: Comparative effects on blood volume expansion, dopamine infusion and isoproterenol infusion on mismatch of ventilation and pulmonary blood flow in peritonitis
100. Effects of low-dose dobutamine on left ventricular diastolic filling in children
101. Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals
102. Cardiovascular responses to dobutamine determined by systolic time intervals in preterm infants
103. Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients
104. Dobutamine infusions in stable, critically ill children: Pharmacokinetics and hemodynamic actions
105. Dobutamine pharmacokinetics and pharmacodynamics and cardiovascular responses in critically ill neonates
106. Dobutamine: A hemodynamic evaluation in children with shock
107. Adjuvant effects of beta-adrenergic drugs on indomethacin treatment of newborn canine endotoxic shock
108. Supranormal cardiac output in the dopamine- and dobutamine-dependent preterm infant
109. Effects of epinephrine on hemodynamics and oxygen metabolism in dopamine-resistant septic shock
110. Epinephrine impairs splanchnic perfusion in septic shock
111. A comparison of the hemodynamic effects of amrinone and sodium nitroprusside in infants after cardiac surgery
112. Amrinone vs copamine-nitroglycerin after reconstructive surgery for complete atrioventricular septal defect
113. Hemodynamic effects of amrinone in children after Fontan surgery
114. Milrinone: Systemic and pulmonary hemodynamics effects in neonates after cardiac surgery
115. The use of inotropic and afterload-reducing agents in neonates
116. Clinical experience with systemic vasodilator therapy in the newborn infant
117. Nitrosovasodilator therapy for severe respiratory distress syndrome
118. Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates
119. Deficiency of prostacyclin production in meningococcal shock
120. Pentoxifylline reduces plasma tumor necrosis factor-alpha concentration in premature infants with sepsis
121. Circulatory and diuretic effects of dopexamine infusion in low-birth-weight infants with respiratory failure
122. Hemodynamic and renal effects of dopexamine after cardiac surgery in children
123. Low plasma ionized calcium and response to calcium therapy in critically ill man
124. Hypocalcemia in critically ill children
125. Adrenal insufficiency in septic shock
126. Fatal childhood pneumococcal Waterhouse-Friderichsen syndrome
127. Endocrine, mineral, and metabolic disease in pediatric intensive care
128. Corticosteroids in septic shock: Resurrection of the last rites?
129. Haemodynamic improvement in refractory septic shock with cortisol replacement therapy
130. Hypocortisolaemia and adrenocortical responsiveness at onset of septic shock
131. Corticosteroid therapy for patients with toxic shock syndrome
132. Hydrocortisone treatment of endotoxin shock: Another paradox in pediatrics
133. Tri-iodothyronine treatment in children after cardiac surgery a double-blind, randomized, placebo-controlled study
134. Endocrine and metabolic responses in children with meningococcal sepsis: Striking differences between survivors and nonsurvivors
135. Admission cortisol and adrenocorticotropin hormone levels in children with meningococcal disease: Evidence of adrenal insufficiency?
136. Adrenal insufficiency occurring during septic shock: Incidence, outcome, and relationship to peripheral cytokine levels
137. Study of adrenal function in children with meningitis
138. Use and dosage of hydrocortisone in endotoxic shock
139. Care of the critically ill child: Endotoxic shock
140. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn: The Inhaled Nitric Oxide Study Group
141. Inhaled nitric oxide in full term and nearly full-term infants with hypoxic respiratory failure
142. Management of infants with severe respiratory failure and persistence of the fetal circulation, without hyperventilation
143. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension need to be taken into consideration when using these drugs
144. Use of cardiotonic therapy in the management of infants with PPHN
145. Vasodilators in persistent pulmonary hypertension of the newborn: A need for optimal appraisal of efficacy
146. Hemodynamic consequences of tolazoline in neonatal group B streptococcal bacteremia: An animal model
147. Clinical and echocardiographic evidence suggesting afterload reduction as a mechanism of action of tolazoline in neonatal hypoxemia
148. Use of sodium nitroprusside in neonates: Efficacy and safety
149. Extracorporeal life support: The University of Michigan experience
150. Results of extracorporeal membrane oxygenation in neonates with sepsis: The Extracorporeal Life Support Organization experience
151. Survivors of extracorporeal oxygenation at 1 year of age: The relationship of primary diagnosis with health and neurodevelopmental sequalae
152. The collaborative UK ECMO (Extracorporeal Membrane Oxygenation) trial: Follow-up to 1 year of age
153. Results of extracorporeal membrane oxygenation in children with sepsis: The Extracorporeal Life Support Organization
154. Extracorporeal support for intractable cardiorespiratory failure due to meningococcal disease
155. Extracorporeal membrane oxygenation for refractory septic shock in children
156. Extracorporeal membrane oxygenation for cardiac rescue in children with severe myocardial dysfunction
157. Cardiopulmonary manifestations of hanta-virus pulmonary syndrome
158. Successful treatment of adults with hanta-virus pulmonary syndrome with ECMO
159. Hemodynamics in normal children
160. Report of the Second Task Force on Blood Pressure Control in Children 1987